Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Laser marking of a card
Method of making a CIG target by cold spraying
Light emitting device
Question and answer system wherein experts are associated with models and have response rates that are associated with time intervals
Over the counter medicinal container with surface ornamentation
Gestures for presentation of different views of a system diagram
Systems and methods for economic retirement analysis
  Randomly Featured Patents
Cover breaker mechanism
Method and apparatus of injection molding a cover with a hole
Method and apparatus enabling thermal energy recovery in combustor operation
Portable analyte measuring system for multiple fluid samples
Lens module
Beverage production
Methods and apparatus for facilitating analysis of large data sets
Print control of a print job to be printed to a plurality of printers
Method of making pigment concentrate particles and product of same
Roller chain for a linear guideway